SNWV
SANUWAVE Health, Inc.
Price Chart
Latest Quote
$9.21
| Previous Close | $9.09 |
| Open | $9.15 |
| Day High | $9.69 |
| Day Low | $8.75 |
| Volume | 284,923 |
Stock Information
| Shares Outstanding | 8.60M |
| Total Debt | $22.16M |
| Cash Equivalents | $10.78M |
| Revenue | $44.34M |
| Net Income | $16.49M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $79.20M |
| P/E Ratio | 9.59 |
| EPS (TTM) | $0.96 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $84.56M |
| Sales | $44.34M |
| Income | $16.49M |
| Book/sh | $0.19 |
| Cash/sh | $1.25 |
| Employees | 55 |
Financial Ratios
| Quick Ratio | 0.92 |
| Current Ratio | 1.31 |
| Debt/Eq | 1205.88 |
Returns & Margins
| ROA | 8.81% |
| Gross Margin | 76.74% |
| Operating Margin | -11.68% |
| Profit Margin | 37.20% |
Ownership
| Insider Ownership | 1.31% |
| Institutional Ownership | 47.23% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -921.00 |
| P/S | 1.79 |
| P/B | 48.99 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $14.53 |
| SMA50 | $16.28 |
| SMA200 | $25.88 |
| RSI | 16.20 |
| ATR | 1.3686 |
| Shares Float | 5.79M |
| Short Float | 13.70% |
| Short Ratio | 6.89 |
| Volatility | 1.34 |
| Rel Volume | 1.89 |
Performance History
| Week | -37.30% |
| Month | -44.82% |
| Quarter | -55.12% |
| 6 Months | -70.72% |
| YTD | -68.12% |
| Year | -69.19% |
| 10 Years | -29.29% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $9.21 | 290,700 |
| 2026-06-17 | $9.09 | 555,800 |
| 2026-06-16 | $8.51 | 1,039,500 |
| 2026-06-15 | $14.67 | 73,700 |
| 2026-06-12 | $14.91 | 77,100 |
| 2026-06-11 | $14.69 | 79,200 |
| 2026-06-10 | $14.38 | 57,800 |
| 2026-06-09 | $14.52 | 38,600 |
| 2026-06-08 | $14.55 | 78,100 |
| 2026-06-05 | $14.76 | 55,400 |
| 2026-06-04 | $15.39 | 110,300 |
| 2026-06-03 | $15.60 | 73,000 |
| 2026-06-02 | $15.09 | 63,700 |
| 2026-06-01 | $15.85 | 53,200 |
| 2026-05-29 | $16.47 | 49,300 |
| 2026-05-28 | $16.66 | 83,500 |
| 2026-05-27 | $16.31 | 74,400 |
| 2026-05-26 | $16.26 | 77,600 |
| 2026-05-22 | $16.69 | 93,900 |
| 2026-05-21 | $17.00 | 51,500 |
| 2026-05-20 | $16.75 | 75,000 |
| 2026-05-19 | $16.69 | 51,700 |
About SANUWAVE Health, Inc.
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and chronic wounds. The company was founded in 2004 and is headquartered in Eden Prairie, Minnesota.
đ° Latest News
Top Midday Decliners
MT Newswires âĸ 2026-06-16T18:29:16ZSANUWAVE Health Inc (SNWV) Q1 2026 Earnings Call Highlights: Record Revenue Amid Market Challenges
GuruFocus.com âĸ 2026-05-13T23:01:23ZSanuwave Health Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-13T18:09:39ZSANUWAVE Health Inc Reports Q1 2026 Results: Full Earnings Call Transcript
Benzinga âĸ 2026-05-13T13:51:53ZSANUWAVE Health, Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-13T12:30:00ZSanuwave Health Inc. (SNWV) Reports Q1 Loss, Beats Revenue Estimates
Zacks âĸ 2026-05-12T23:00:04ZHow The SANUWAVE Health (SNWV) Investment Story Is Shifting Around The US$43.50 Target
Simply Wall St. âĸ 2026-05-12T07:13:15Zbiote Corp. (BTMD) Q1 Earnings and Revenues Lag Estimates
Zacks âĸ 2026-05-06T22:30:19ZWill MacroGenics (MGNX) Report Negative Q1 Earnings? What You Should Know
Zacks âĸ 2026-05-05T14:00:06ZSanuwave Health Inc. (SNWV) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Zacks âĸ 2026-05-01T14:00:10ZIncome Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $9,679,000 | $7,728,000 | $5,759,000 | $4,145,000 |
| Cost Of Revenue | $10,082,000 | $8,084,000 | $6,035,000 | $4,331,000 |
| Total Revenue | $44,051,000 | $32,634,000 | $20,398,000 | $16,742,000 |
| Operating Revenue | $44,051,000 | $32,634,000 | $20,398,000 | $16,742,000 |
| Expenses | ||||
| Interest Expense | $6,246,000 | $13,779,000 | $15,623,000 | $14,132,000 |
| Total Expenses | $39,106,000 | $28,786,000 | $20,938,000 | $25,694,000 |
| Other Income Expense | $13,200,000 | $-23,125,000 | $-9,640,000 | $16,227,000 |
| Other Non Operating Income Expenses | $5,766,000 | $1,962,000 | $-19,000 | $-9,000 |
| Net Non Operating Interest Income Expense | $-6,246,000 | $-13,779,000 | $-15,623,000 | $-17,566,000 |
| Interest Expense Non Operating | $6,246,000 | $13,779,000 | $15,623,000 | $14,132,000 |
| Operating Expense | $29,024,000 | $20,702,000 | $14,903,000 | $21,363,000 |
| Selling And Marketing Expense | $7,419,000 | $6,323,000 | $4,898,000 | $7,474,000 |
| General And Administrative Expense | $19,372,000 | $12,917,000 | $8,674,000 | $12,556,000 |
| Total Other Finance Cost | - | - | - | $3,434,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $11,813,000 | $-33,083,000 | $-25,807,000 | $-10,293,000 |
| Net Interest Income | $-6,246,000 | $-13,779,000 | $-15,623,000 | $-17,566,000 |
| Normalized Income | $4,431,038 | $-13,264,270 | $-18,206,410 | $-23,119,440 |
| Net Income From Continuing And Discontinued Operation | $11,813,000 | $-33,083,000 | $-25,807,000 | $-10,293,000 |
| Total Operating Income As Reported | $4,945,000 | $3,848,000 | $-540,000 | $-8,952,000 |
| Net Income Common Stockholders | $11,813,000 | $-33,083,000 | $-25,807,000 | $-10,293,000 |
| Net Income | $11,813,000 | $-33,083,000 | $-25,807,000 | $-10,293,000 |
| Net Income Including Noncontrolling Interests | $11,813,000 | $-33,083,000 | $-25,807,000 | $-10,293,000 |
| Net Income Continuous Operations | $11,813,000 | $-33,083,000 | $-25,807,000 | $-10,293,000 |
| Pretax Income | $11,899,000 | $-33,056,000 | $-25,803,000 | $-10,291,000 |
| Special Income Charges | $-673,000 | $6,326,000 | $0 | $-418,000 |
| Operating Income | $4,945,000 | $3,848,000 | $-540,000 | $-8,952,000 |
| Depreciation Amortization Depletion Income Statement | $880,000 | $789,000 | $752,000 | $766,000 |
| Depreciation And Amortization In Income Statement | $880,000 | $789,000 | $752,000 | $766,000 |
| Depreciation Income Statement | $880,000 | $789,000 | $752,000 | $766,000 |
| Gross Profit | $33,969,000 | $24,550,000 | $14,363,000 | $12,411,000 |
| Per Share | ||||
| Diluted EPS | $0.41 | $-7.03 | $-12.19 | $-7.50 |
| Basic EPS | $1.38 | $-7.03 | $-12.19 | $-7.50 |
| Other | ||||
| Tax Effect Of Unusual Items | $52,038 | $-5,268,270 | $-2,020,410 | $3,409,560 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $11,994,000 | $6,955,000 | $469,000 | $-11,443,000 |
| Total Unusual Items | $7,434,000 | $-25,087,000 | $-9,621,000 | $16,236,000 |
| Total Unusual Items Excluding Goodwill | $7,434,000 | $-25,087,000 | $-9,621,000 | $16,236,000 |
| Reconciled Depreciation | $1,283,000 | $1,145,000 | $1,028,000 | $952,000 |
| EBITDA (Bullshit earnings) | $19,428,000 | $-18,132,000 | $-9,152,000 | $4,793,000 |
| EBIT | $18,145,000 | $-19,277,000 | $-10,180,000 | $3,841,000 |
| Diluted Average Shares | $9,082,510 | $4,462,883 | $2,116,936 | $1,465,255 |
| Basic Average Shares | $8,563,510 | $4,462,883 | $2,116,936 | $1,465,255 |
| Diluted NI Availto Com Stockholders | $11,813,000 | $-33,083,000 | $-25,807,000 | $-10,293,000 |
| Tax Provision | $86,000 | $27,000 | $4,000 | $2,000 |
| Other Special Charges | $477,000 | $-6,326,000 | - | $418,000 |
| Impairment Of Capital Assets | $196,000 | $0 | - | - |
| Gain On Sale Of Security | $8,107,000 | $-31,413,000 | $-9,621,000 | $16,654,000 |
| Research And Development | $1,353,000 | $673,000 | $579,000 | $567,000 |
| Selling General And Administration | $26,791,000 | $19,240,000 | $13,572,000 | $20,030,000 |
| Other Gand A | $19,372,000 | $12,917,000 | $8,674,000 | $12,556,000 |
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-8,667,000 | $-26,785,000 | $-54,872,000 | $-53,407,000 |
| Total Assets | $37,343,000 | $30,119,000 | $22,416,000 | $19,873,000 |
| Total Non Current Assets | $12,716,000 | $11,722,000 | $12,632,000 | $13,253,000 |
| Other Non Current Assets | $68,000 | - | - | $106,000 |
| Goodwill And Other Intangible Assets | $10,286,000 | $10,990,000 | $11,694,000 | $12,397,000 |
| Other Intangible Assets | $3,026,000 | $3,730,000 | $4,434,000 | $5,137,000 |
| Current Assets | $24,627,000 | $18,397,000 | $9,784,000 | $6,620,000 |
| Other Current Assets | $1,312,000 | $682,000 | $1,722,000 | $570,000 |
| Inventory | $5,934,000 | $4,149,000 | $2,951,000 | $868,000 |
| Receivables | $5,422,000 | $3,329,000 | $3,314,000 | $4,029,000 |
| Accounts Receivable | $5,422,000 | $3,329,000 | $3,314,000 | $4,029,000 |
| Allowance For Doubtful Accounts Receivable | $-1,265,000 | $-1,147,000 | $-1,237,000 | $-1,037,000 |
| Gross Accounts Receivable | $6,687,000 | $4,476,000 | $4,551,000 | $5,066,000 |
| Cash Cash Equivalents And Short Term Investments | $11,959,000 | $10,237,000 | $1,797,000 | $1,153,000 |
| Cash And Cash Equivalents | $11,959,000 | $10,237,000 | $1,797,000 | $1,153,000 |
| Cash Financial | - | $10,237,000 | $1,797,000 | $1,153,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $10,001,000 | $15,068,000 | $28,165,000 | $37,385,000 |
| Total Debt | $22,971,000 | $25,797,000 | $30,454,000 | $38,976,000 |
| Long Term Debt And Capital Lease Obligation | $17,176,000 | $191,000 | $492,000 | $438,000 |
| Long Term Debt | $16,322,000 | - | - | - |
| Current Debt And Capital Lease Obligation | $5,795,000 | $25,606,000 | $29,962,000 | $38,538,000 |
| Current Debt | $5,638,000 | $25,305,000 | $29,962,000 | $38,538,000 |
| Other Current Borrowings | $5,638,000 | - | $7,109,000 | $24,122,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $35,724,000 | $45,914,000 | $65,594,000 | $60,883,000 |
| Total Non Current Liabilities Net Minority Interest | $17,877,000 | $491,000 | $839,000 | $668,000 |
| Non Current Deferred Liabilities | $701,000 | $300,000 | $347,000 | $230,000 |
| Current Liabilities | $17,847,000 | $45,423,000 | $64,755,000 | $60,215,000 |
| Other Current Liabilities | $7,000 | $8,140,000 | $16,884,000 | $3,865,000 |
| Current Deferred Liabilities | $388,000 | $193,000 | $92,000 | $60,000 |
| Current Notes Payable | $0 | $25,305,000 | $22,853,000 | $14,416,000 |
| Payables And Accrued Expenses | $10,437,000 | $9,252,000 | $15,519,000 | $13,167,000 |
| Interest Payable | $24,000 | $0 | $6,113,000 | $4,840,000 |
| Payables | $8,171,000 | $6,806,000 | $5,705,000 | $4,400,000 |
| Other Payable | $32,000 | $44,000 | - | - |
| Total Tax Payable | $4,920,000 | $3,078,000 | - | - |
| Accounts Payable | $3,219,000 | $3,684,000 | $5,705,000 | $4,400,000 |
| Non Current Deferred Taxes Liabilities | - | - | - | $28,000 |
| Equity | ||||
| Common Stock Equity | $1,619,000 | $-15,795,000 | $-43,178,000 | $-41,010,000 |
| Total Equity Gross Minority Interest | $1,619,000 | $-15,795,000 | $-43,178,000 | $-41,010,000 |
| Stockholders Equity | $1,619,000 | $-15,795,000 | $-43,178,000 | $-41,010,000 |
| Gains Losses Not Affecting Retained Earnings | $10,000 | $10,000 | $-111,000 | $-67,000 |
| Other Equity Adjustments | $10,000 | $10,000 | $-111,000 | $-67,000 |
| Retained Earnings | $-242,685,000 | $-254,499,000 | $-220,049,000 | $-194,242,000 |
| Other | ||||
| Ordinary Shares Number | $8,588,876 | $8,543,686 | $3,041,492 | $1,463,300 |
| Share Issued | $8,588,876 | $8,543,686 | $3,041,492 | $1,463,300 |
| Tangible Book Value | $-8,667,000 | $-26,785,000 | $-54,872,000 | $-53,407,000 |
| Invested Capital | $23,579,000 | $9,510,000 | $-13,216,000 | $-2,472,000 |
| Working Capital | $6,780,000 | $-27,026,000 | $-54,971,000 | $-53,595,000 |
| Capital Lease Obligations | $1,011,000 | $492,000 | $492,000 | $438,000 |
| Total Capitalization | $17,941,000 | $-15,795,000 | $-43,178,000 | $-41,010,000 |
| Additional Paid In Capital | $244,285,000 | $238,685,000 | $176,979,000 | $152,750,000 |
| Capital Stock | $9,000 | $9,000 | $3,000 | $549,000 |
| Common Stock | $9,000 | $9,000 | $3,000 | $549,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Non Current Deferred Revenue | $701,000 | $300,000 | $347,000 | $230,000 |
| Long Term Capital Lease Obligation | $854,000 | $191,000 | $492,000 | $438,000 |
| Current Deferred Revenue | $388,000 | $193,000 | $92,000 | $60,000 |
| Current Capital Lease Obligation | $157,000 | $301,000 | - | - |
| Pensionand Other Post Retirement Benefit Plans Current | $1,220,000 | $2,232,000 | $2,298,000 | $4,585,000 |
| Current Accrued Expenses | $2,266,000 | $2,446,000 | $9,814,000 | $8,767,000 |
| Goodwill | $7,260,000 | $7,260,000 | $7,260,000 | $7,260,000 |
| Net PPE | $2,362,000 | $732,000 | $938,000 | $856,000 |
| Accumulated Depreciation | $-358,000 | $-460,000 | - | - |
| Gross PPE | $2,720,000 | $1,192,000 | - | $750,000 |
| Other Properties | $1,413,000 | $460,000 | - | $750,000 |
| Machinery Furniture Equipment | $1,307,000 | $732,000 | - | - |
| Inventories Adjustments Allowances | $-213,000 | $-369,000 | $-347,000 | $-343,000 |
| Finished Goods | $6,012,000 | $755,000 | $416,000 | $570,000 |
| Raw Materials | $135,000 | $3,763,000 | $2,535,000 | $641,000 |
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $1,934,000 | $1,965,000 | $-4,538,000 | $-17,169,000 |
| Operating Activities | ||||
| Operating Cash Flow | $3,876,000 | $2,455,000 | $-4,538,000 | $-17,169,000 |
| Cash Flow From Continuing Operating Activities | $3,876,000 | $2,455,000 | $-4,538,000 | $-17,169,000 |
| Operating Gains Losses | $-12,795,000 | $25,087,000 | $9,621,000 | $-16,236,000 |
| Investing Activities | ||||
| Capital Expenditure | $-1,942,000 | $-490,000 | - | - |
| Investing Cash Flow | $3,433,000 | $-490,000 | $21,000 | $332,000 |
| Cash Flow From Continuing Investing Activities | $3,433,000 | $-490,000 | $21,000 | $332,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $10,300,000 | $0 | - |
| Financing Cash Flow | $-5,587,000 | $6,354,000 | $5,211,000 | $17,384,000 |
| Cash Flow From Continuing Financing Activities | $-5,587,000 | $6,354,000 | $5,211,000 | $17,384,000 |
| Net Other Financing Charges | $-371,000 | $-1,490,000 | $-639,000 | $695,000 |
| Net Common Stock Issuance | $0 | $10,300,000 | $0 | - |
| Common Stock Issuance | $0 | $10,300,000 | $0 | - |
| Net Preferred Stock Issuance | - | - | - | - |
| Preferred Stock Issuance | - | - | - | - |
| Other | ||||
| Repayment Of Debt | $-29,427,000 | $-4,256,000 | $-170,000 | $-3,218,000 |
| Issuance Of Debt | $23,655,000 | $1,800,000 | $6,020,000 | $19,807,000 |
| Interest Paid Supplemental Data | $3,744,000 | $4,311,000 | $1,958,000 | $3,712,000 |
| Income Tax Paid Supplemental Data | $27,000 | $4,000 | - | - |
| End Cash Position | $11,959,000 | $10,237,000 | $1,797,000 | $1,153,000 |
| Beginning Cash Position | $10,237,000 | $1,797,000 | $1,153,000 | $619,000 |
| Effect Of Exchange Rate Changes | $0 | $121,000 | $-50,000 | $-13,000 |
| Changes In Cash | $1,722,000 | $8,319,000 | $694,000 | $547,000 |
| Proceeds From Stock Option Exercised | $556,000 | $0 | $0 | $100,000 |
| Net Issuance Payments Of Debt | $-5,772,000 | $-2,456,000 | $5,850,000 | $16,589,000 |
| Net Short Term Debt Issuance | $-27,747,000 | $-2,248,000 | $6,020,000 | $16,867,000 |
| Short Term Debt Payments | $-27,747,000 | $-4,048,000 | $0 | - |
| Short Term Debt Issuance | $0 | $1,800,000 | $6,020,000 | $16,867,000 |
| Net Long Term Debt Issuance | $21,975,000 | $-208,000 | $-170,000 | $-278,000 |
| Long Term Debt Payments | $-1,680,000 | $-208,000 | $-170,000 | $-3,218,000 |
| Long Term Debt Issuance | $23,655,000 | $0 | $0 | $2,940,000 |
| Net Intangibles Purchase And Sale | $5,375,000 | $0 | - | - |
| Sale Of Intangibles | $5,375,000 | $0 | - | - |
| Net PPE Purchase And Sale | $-1,942,000 | $-490,000 | $21,000 | $332,000 |
| Purchase Of PPE | $-1,942,000 | $-490,000 | $0 | - |
| Change In Working Capital | $-4,015,000 | $-1,192,000 | $-3,606,000 | $-1,119,000 |
| Change In Other Current Liabilities | $-156,000 | $0 | - | - |
| Change In Payables And Accrued Expense | $1,444,000 | $571,000 | $-547,000 | $701,000 |
| Change In Accrued Expense | $1,965,000 | $1,993,000 | $-2,093,000 | $3,251,000 |
| Change In Payable | $-521,000 | $-1,422,000 | $1,546,000 | $-2,550,000 |
| Change In Account Payable | $-521,000 | $-1,422,000 | $1,546,000 | $-2,550,000 |
| Change In Prepaid Assets | $-724,000 | $-79,000 | $-206,000 | - |
| Change In Inventory | $-2,283,000 | $-1,198,000 | $-2,800,000 | $-72,000 |
| Change In Receivables | $-2,296,000 | $-486,000 | $-53,000 | $-1,748,000 |
| Changes In Account Receivables | $-2,296,000 | $-486,000 | $-53,000 | $-1,748,000 |
| Other Non Cash Items | $2,040,000 | $8,907,000 | $13,441,000 | $9,272,000 |
| Stock Based Compensation | $4,850,000 | $1,514,000 | $0 | - |
| Provisionand Write Offof Assets | $202,000 | $77,000 | $781,000 | $253,000 |
| Asset Impairment Charge | $498,000 | $0 | $781,000 | $253,000 |
| Depreciation Amortization Depletion | $1,283,000 | $1,145,000 | $1,028,000 | $952,000 |
| Depreciation And Amortization | $1,283,000 | $1,145,000 | $1,028,000 | $952,000 |
| Depreciation | $1,283,000 | $1,145,000 | $1,028,000 | $952,000 |
| Gain Loss On Investment Securities | $-8,107,000 | $31,413,000 | $9,621,000 | $-16,654,000 |
| Gain Loss On Sale Of PPE | $-5,375,000 | $0 | - | - |
| Net Income From Continuing Operations | $11,813,000 | $-33,083,000 | $-25,807,000 | $-10,293,000 |
| Sale Of PPE | - | $0 | $21,000 | $332,000 |
| Deferred Tax | - | $0 | $4,000 | $2,000 |
| Deferred Income Tax | - | $0 | $4,000 | $2,000 |
| Change In Interest Payable | - | - | $6,306,000 | $3,182,000 |
| Net Business Purchase And Sale | - | - | - | - |
| Purchase Of Business | - | - | - | - |
| Change In Other Working Capital | - | - | - | - |
| Change In Other Current Assets | - | - | - | - |
| Amortization Cash Flow | - | - | - | - |
| Amortization Of Intangibles | - | - | - | - |